AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TALPHERA, INC. Director's Dealing 2013

Mar 5, 2013

35181_dirs_2013-03-05_381c140f-3974-4b8e-8efb-c67cbc4d8a28.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2013-03-02

Reporting Person: Dasu Badri N (Chief Engineering Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-03-02	Common Stock	F	1363	$4.96	Disposed	18139	Direct

Footnotes

F1: The shares were withheld to satisfy tax liability upon vesting 25% of the restricted stock units of the Company, previously reported on March 4, 2011.